» Articles » PMID: 2787640

Antibodies to Histones H1 and H5 in Sera of Patients with Juvenile Rheumatoid Arthritis

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 1989 Jul 1
PMID 2787640
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The specificity of juvenile rheumatoid arthritis (JRA) sera for histone subclasses was examined by immunoblotting. Antibodies to H1 alone were found in 4 of 21 pauciarticular-onset JRA sera, 4 of 19 polyarticular-onset JRA sera, and 2 of 11 systemic-onset JRA sera. Antibodies to H5 alone were found in 1 of 21 pauciarticular JRA sera, 1 of 19 polyarticular JRA sera, and 3 of 11 systemic JRA sera. Antibodies to both H1 and H5 were found in 4 of 21 pauciarticular JRA sera, 4 of 19 polyarticular JRA sera, and 1 of 11 systemic JRA sera. Antibodies to the core histones (H2A and H2B) were found in 1 of 21 pauciarticular JRA sera, 1 of 19 polyarticular JRA sera, and no systemic JRA sera. No reactivity to histones was observed in 30 sera from age-matched children with nonrheumatic diseases. The presence of H1 and H5 antibodies did not correlate with antinuclear antibody titers or with a homogeneous pattern of immunofluorescence. The predominance of H1 and H5 antibodies and relative absence of antibodies binding to core histones in JRA contrast with findings in adult systemic lupus erythematosus. Further, the presence of antibodies to H5 alone in some of the JRA patients indicates that the immune response in these patients is directed to determinants that are not shared by sequences of mammalian proteins.

Citing Articles

Antibodies to histone in the pediatric population: a retrospective chart review.

Justice C, Moore T Pediatr Rheumatol Online J. 2023; 21(1):40.

PMID: 37098546 PMC: 10131474. DOI: 10.1186/s12969-023-00821-y.


Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course.

Hugle B, Hinze C, Lainka E, Fischer N, Haas J Pediatr Rheumatol Online J. 2014; 12:28.

PMID: 25114627 PMC: 4127434. DOI: 10.1186/1546-0096-12-28.


Antinucleosome antibodies in juvenile chronic arthritis.

Nisihara R, Skare T, Silva M, Silva R, Silva D Clin Rheumatol. 2009; 28(12):1461-3.

PMID: 19789936 DOI: 10.1007/s10067-009-1282-0.


DEK binding to class II MHC Y-box sequences is gene- and allele-specific.

Adams B, Cha H, Cleary J, Haiying T, Wang H, Sitwala K Arthritis Res Ther. 2003; 5(4):R226-33.

PMID: 12823858 PMC: 165066. DOI: 10.1186/ar774.


Clinical relevance of autoantibodies in systemic rheumatic diseases.

Fritzler M Mol Biol Rep. 1996; 23(3-4):133-45.

PMID: 9112221 DOI: 10.1007/BF00351161.